医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

2015 Q4 Index Closes with Historically High Demand

2016年02月19日 PM10:00
このエントリーをはてなブックマークに追加


 

ROCHELLE PARK, N.J.

ZRG Partners has announced the findings for the fourth quarter Global Life Sciences Hiring Index. Posted hiring activity levels are nearly 30% higher than a year ago.

Outsourcing Services continues to show expansion, steadily increasing hiring levels over 30% since the beginning of the year.

ZRG European President and Global Practice Head of Life Sciences, Adam El Din commented, “Commercial positions will likely continue to shrink in the near future, driven down by industry mergers; the expiration of blockbuster drug patents; and a shift toward flexible, regional, and specialized sales teams.”

David Fortier, Managing Director – Global Life Sciences added, “While the quarterly changes do not reflect a consistent upward trend, the growth from the previous year and overall hiring levels show confidence across virtually all sectors and geographies. This strength results in part from exciting new science and a willing investment base for both established and new companies to pursue these new therapies.”

About ZRG Partners

ZRG Partners, LLC is a global authority on talent management in the Life Sciences, Pharmaceutical and Medical Device markets. ZRG provides its clients with specialized global market expertise in executive recruitment, consulting and advisory work with a focus on data and analytics to drive great business decisions.

The Global Life Sciences Hiring Index analysis utilizes a proprietary algorithm that looks at hiring within selected benchmark companies in three distinct segments. The companies in the index generate over $630 billion in revenues and employ over 1.5 million people globally. ZRG Partners conducts extensive direct market research in developing the data that drives the Index.

For more information about ZRG please go to zrgpartners.com.

View source version on businesswire.com: http://www.businesswire.com/news/home/20160219005426/en/

CONTACT

For press requests or for permission to use this data in other media
form:
ZRG Partners
Adam
El Din
, +41-22-319-3304
European President and Global Practice
Head of Life Sciences in Switzerland
or
David
Fortier
, +1-202-525-1341
Managing Director in the USA

Related Posts Plugin for WordPress, Blogger...

同じカテゴリーの記事 

  • Seagen and Astellas Announce Phase 3 Trial Results Demonstrating Survival Advantage of PADCEV® (enfortumab vedotin-ejfv) in Patients with Previously Treated Advanced Urothelial Cancer
  • No Dogs Left Behind Meat Market Survivors Coming Home
  • Takeda’s Maribavir Phase 3 Clinical Trial Met Primary Endpoint of Superiority to Conventional Antiviral Therapy in Transplant Recipients With Refractory, With or Without Resistance, Cytomegalovirus Infection/Disease
  • Modra Pharmaceuticals于2021 ASCO GU年会公布其转移性前列腺癌IIb期临床试验初步数据
  • MSCIの調査結果:世界の投資家はパンデミックに対応してESG投資を加速、相互関連するリスクが課題に